mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease

Area of Science:

• Molecular biology
• Bioinformatics
• Hepatology

Background:

• Non-alcoholic fatty liver disease (NAFLD) is a growing global health concern.
• The molecular mechanisms underlying NAFLD pathogenesis are complex and not fully understood.
• Identifying key regulatory networks is crucial for understanding NAFLD progression.

Purpose of the Study:

• To construct a bioinformatics-based co-regulatory network of mRNAs and non-coding RNAs (ncRNAs) involved in NAFLD.
• To validate the identified network in a relevant NAFLD animal model.
• To provide insights into the molecular mechanisms and potential therapeutic targets for NAFLD.

Main Methods:

• Utilized bioinformatics tools to retrieve and construct the mRNA-miRNA-lncRNA regulatory network.
• Employed a high-sucrose and high-fat diet (HSHF)-fed rat model to simulate NAFLD.
• Assessed the expression levels of network components in liver tissues using reverse transcriptase real-time polymerase chain reaction (RT-qPCR).

Main Results:

• Identified a co-regulatory network comprising six mRNAs (YAP1, FOXA2, AMOTL2, TEAD2, SMAD4, NF2), two miRNAs (miR-650, miR-1205), and two lncRNAs (RPARP-AS1, SRD5A3-AS1) crucial for NAFLD pathogenesis.
• Demonstrated significantly different expression levels of these network players between NAFLD and normal control groups.
• The in-silico constructed network was validated in the HSHF-fed rat model.

Conclusions:

• The study elucidates a novel RNA co-regulatory network implicated in NAFLD pathogenesis.
• The findings offer new insights into the molecular mechanisms driving NAFLD.
• The identified RNA network presents potential biomarkers for NAFLD diagnosis and therapeutic targets for management strategies.